Physician

Vinay C Tumuluri, MD

According to 2025 Medicare claims, Vinay Tumuluri, MD (NPI: 1528015344) practices internal medicine in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is LA PORTE CLINIC COMPANY LLC (NPI: 1568829224; TIN: 810745237) and primary practice location at 46360-9198. Tumuluri is affiliated with the CHSPSC ACO 21, LLC (ACO ID: A3698), participating under the MSSP model.

Tumuluri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 718 traditional Medicare patients, billed 3,970 HCPCS/CPT codes, and received $226,639 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 18,469 prescription claims across 1,159 beneficiaries totaling $2,742,085 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 889 claims. Open Payments data shows 192 records totaling $3,901. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $654,774 to $2,742,085. For DME billing, reported payments moved sharply higher in recent years, from $47,281 to $110,482.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	888	8,059	$173,361
2016	814	9,094	$190,550
2017	841	4,503	$192,300
2018	847	4,559	$213,811
2019	886	5,029	$223,350
2020	812	4,206	$212,379
2021	798	4,378	$240,040
2022	746	3,882	$216,515
2023	742	4,375	$221,398
2024	718	3,970	$226,639

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	545	6,675	$654,774
2016	624	8,342	$863,154
2017	700	10,467	$1,030,383
2018	807	12,342	$1,427,882
2019	952	15,043	$1,765,316
2020	927	15,645	$1,878,723
2021	944	16,615	$2,242,433
2022	1,050	17,674	$2,505,604
2023	1,081	17,818	$3,172,218
2024	1,159	18,469	$2,742,085

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	197	893	$49,181
2016	206	838	$42,607
2017	200	857	$29,895
2018	224	946	$47,151
2019	301	1,236	$57,335
2020	315	1,151	$65,364
2021	263	996	$79,202
2022	275	974	$95,119
2023	270	1,155	$149,983
2024	161	889	$140,153

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	417	417	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	600	1,542	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	179	279	$51
83036	Hemoglobin a1c level	172	420	$9
82962	Blood glucose (sugar) test performed by hand-held instrument	173	395	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	246	10,900	$399,696
Jardiance	Empagliflozin	196	13,688	$265,772
Ozempic	Semaglutide	170	7,650	$250,428
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	163	10,440	$215,791
Eliquis	Apixaban	161	9,571	$181,298

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	24	125	$44,585
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	24	$20,642
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	21	$14,394
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	32	$13,014
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	12	$8,949

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	192	$3,901	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vinay C. Tumuluri, MD?

Tedicare shows public-source Medicare data for Vinay C. Tumuluri, MD (NPI 1528015344), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vinay C. Tumuluri, MD have ACO affiliation data?

Vinay C. Tumuluri, MD is shown with ACO affiliation data for CHSPSC ACO 21, LLC (MSSP, ACO ID A3698).

What billing organization is linked to Vinay C. Tumuluri, MD?

Vinay C. Tumuluri, MD is linked to LA PORTE CLINIC COMPANY LLC (billing NPI 1568829224) in the available physician profile data.

Does Vinay C. Tumuluri, MD have Open Payments data?

Vinay C. Tumuluri, MD has 192 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.